Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income (loss)	$ 38,632	$ (28,344)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Amortization of debt issuance costs	1,187	1,187
Depreciation and amortization	22,145	21,197
Equity in undistributed earnings of associated companies, net of dividends	(5,105)	4,285
Acquisition-related fair value adjustments related to inventory	801	0
Deferred compensation, deferred taxes and other, net	(9,888)	(22,988)
Share-based compensation	3,779	4,682
Gain on disposal of property, plant and equipment and other assets	(5,410)	(2)
Insurance settlement realized	0	(229)
Indefinite-lived intangible asset impairment	0	38,000
Combination and other acquisition-related expenses, net of payments	(2,884)	(519)
Restructuring and related charges	1,175	1,716
Pension and other postretirement benefit expense	(1,034)	22,453
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable	(46,270)	2,322
Inventories	(24,994)	(10,162)
Prepaid expenses and other current assets	(8,315)	(3,263)
Change in restructuring liabilities	(3,034)	(4,841)
Accounts payable and accrued liabilities	26,597	(5,275)
Net cash (used in) provided by operating activities	(12,618)	20,219
Cash flows from investing activities
Investments in property, plant and equipment	(3,934)	(4,892)
Payments related to acquisitions, net of cash acquired	(26,655)	(3,160)
Proceeds from disposition of assets	14,744	0
Insurance settlement interest earned	0	31
Net cash used in investing activities	(15,845)	(8,021)
Cash flows from financing activities
Payments of long-term debt	(9,551)	(9,371)
Borrowings on revolving credit facilities, net	30,000	205,500
Repayments on other debt, net	(188)	(185)
Dividends paid	(7,052)	(6,828)
Stock options exercised, other	(178)	(696)
Purchase of noncontrolling affiliate shareholders	0	(1,047)
Distributions to noncontrolling affiliate shareholders	0	(751)
Net cash (used in) provided by financing activities	13,031	186,622
Effect of foreign exchange rate changes on cash	(3,008)	(6,424)
Net (decrease) increase in cash, cash equivalents and restricted cash	(18,440)	192,396
Cash, cash equivalents and restricted cash at the beginning of the period	181,895	143,555
Cash, cash equivalents and restricted cash at the end of the period	$ 163,455	$ 335,951